In this free webinar, gain insights into ophthalmology trial design considerations and strategies. Attendees will learn best practices for presenting ophthalmic data. The featured speakers will discuss key considerations on statistical reporting of ophthalmic studies to Data Monitoring Committees.
TORONTO, Jan. 18, 2024 /PRNewswire-PRWeb/ -- Discover a groundbreaking webinar delving into the statistical data strategies and considerations of ophthalmology clinical trials, as well as supporting Data Monitoring Committees (DMC) charged with safety and efficacy reviews.
The choice of design for ophthalmology clinical trials requires careful consideration of the nature of the ophthalmic disease, the severity of the disease in each eye and the treatment being investigated. Trial designs that maximize data from each consideration are ideal. Therefore, it is imperative to rely on robust statistical methods provided by experienced statisticians, as they play a crucial role in effectively addressing these challenges and supporting the design and analysis of ophthalmology clinical trials.
Additionally, it is crucial to implement effective strategies for establishing DMCs and reporting to these committees in order to ensure successful execution. By creating well-crafted presentations that accurately represent ophthalmic assessments in a meaningful and concise manner, DMCs can provide valuable recommendations to Sponsors. Since ophthalmic assessments encompass various modalities and involve a substantial amount of imaging data, it is essential for statistical reporting teams to carefully synthesize and deliver thoughtful presentations. Furthermore, when dealing with rare indications and ophthalmic Cell and Gene therapy studies, it is imperative to develop efficient and meaningful patient profiles and statistical presentations as important considerations.
Join this webinar to gain insights into ophthalmology clinical trials' statistical data strategies and learn about best practices for establishing and reporting ophthalmic data.
Join experts from Emmes, Maria Abraham, Sr. Manager, Biostatistician; and Supriya Menezes, Associate VP, Ophthalmology Center, for the live webinar on Thursday, February 8, 2024, at 1:30pm CET/EU-Central (7:30am EST).
For more information, or to register for this event, visit Addressing Ophthalmology Clinical Trial Design and Effective Data Monitoring Committee Strategies.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected], www.xtalks.com
SOURCE Xtalks
Share this article